New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Elevance Health Inc.
ELV
Shape
US Flag

NYSE

99B

Medical - Healthcare Plans

Next Earning date - 22 Jan 2025

99B

Medical - Healthcare Plans

Next Earning date - 22 Jan 2025

425.27USD
Shape6.23 ( 1.49%)
favorite-chart

Relative Strenght

51
favorite-chart

Volume Buzz

57%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

25%

Quote Panel

Shape
Updated October 27, 2024
1W 0.71 % 1M -18.22 % 3M -19.50 % 1Y -3.90 %

Key Metrics

Shape
  • Market Cap

    98.63B


  • Shares Outstanding

    231.92M


  • Share in Float

    231.02M


  • Dividende

    6.52


  • Earning Date

    22 Jan 2025


  • Price Target

    425.27


  • Average Volume

    1.18M


  • Beta

    0.828


  • Range

    397.98-567.26


  • Industry

    Medical - Healthcare Plans


  • Website

    https://www.elevancehealth.com


  • Sector

    Healthcare


Fundamentals

Shape

12.24x

P/E Ratio

0.57x

P/S Ratio

2.26x

P/B Ratio

0.6

Debt/Equity

3.7%

Net Margin

$27.5

EPS

How ELV compares to sector?

P/E Ratio

Relative Strength

Shape

ELV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$187B

Shape313%

2025-Revenue

$32.80

Shape649%

2025-EPS

$11B

Shape469%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Bank of America Securities

downgrade

Previous: Buy

2024-07-18

Now: Neutral

Morgan Stanley

upgrade

Previous: Not converted

2023-04-27

Now: Overweight

RBC Capital

upgrade

Previous: Not converted

2023-03-28

Now: Outperform

Bank of America Securities

upgrade

Previous: Not converted

2022-09-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+2%

5.23
vs 5.14

Q1.23

arrow
arrow

+15%

9.46
vs 8.25

Q2.23

arrow
arrow

+12%

9.04
vs 8.04

Q3.23

arrow
arrow

+19%

8.99
vs 7.53

Q4.23

arrow
arrow

+7%

5.62
vs 5.23

Q1.24

arrow
arrow

+12%

10.64
vs 9.46

Q2.24

arrow
arrow

+12%

10.12
vs 9.04

Q3.24

arrow
arrow

-7%

8.37
vs 8.99

Q4.24

arrow
arrow

-22%

4.41
vs 5.62

Q1.25

arrow
arrow

-2%

10.45
vs 10.64

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+9%

39.9B  vs 36.6B

Q1.23

arrow
arrow

+11%

42.2B  vs 38.1B

Q2.23

arrow
arrow

+13%

43.7B  vs 38.6B

Q3.23

arrow
arrow

+7%

42.8B  vs 39.9B

Q4.23

arrow
arrow

+7%

42.6B  vs 39.9B

Q1.24

arrow
arrow

+1%

42.6B  vs 42.2B

Q2.24

arrow
arrow

0%

43.6B  vs 43.7B

Q3.24

arrow
arrow

+5%

45.1B  vs 42.8B

Q4.24

arrow
arrow

+5%

44.8B  vs 42.6B

Q1.25

arrow
arrow

+7%

45.7B  vs 42.6B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+3%

0.03
vs 0.04

Q1.23

arrow
arrow

+5%

0.05
vs 0.03

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+3%

0.03
vs 0.05

Q4.23

arrow
arrow

+2%

0.02
vs 0.03

Q1.24

arrow
arrow

+6%

0.06
vs 0.02

Q2.24

arrow
arrow

+5%

0.05
vs 0.06

Q3.24

arrow
arrow

+2%

0.02
vs 0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

1473

1.5K
vs 1.5K

0%

Q4.22

arrow
arrow

1585

1.6K
vs 1.5K

8%

Q1.23

arrow
arrow

1534

1.5K
vs 1.6K

-3%

Q2.23

arrow
arrow

1545

1.5K
vs 1.5K

1%

Q3.23

arrow
arrow

1555

1.6K
vs 1.5K

1%

Q4.23

arrow
arrow

1687

1.7K
vs 1.6K

8%

Q1.24

arrow
arrow

1700

1.7K
vs 1.7K

1%

Q2.24

arrow
arrow

1709

1.7K
vs 1.7K

1%

Earnings Growth

Latest News